Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,831 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Diabetic retinopathy.
Cheung N, Mitchell P, Wong TY. Cheung N, et al. Among authors: mitchell p. Lancet. 2010 Jul 10;376(9735):124-36. doi: 10.1016/S0140-6736(09)62124-3. Epub 2010 Jun 26. Lancet. 2010. PMID: 20580421 Review.
Relationship of hemoglobin A1c with the presence and severity of retinopathy upon initial screening of type II diabetes mellitus.
Cheung N, Wang JJ, Wong TY, Mitchell P, Klein R. Cheung N, et al. Among authors: mitchell p. Am J Ophthalmol. 2007 Oct;144(4):639-40; author reply 640. doi: 10.1016/j.ajo.2007.06.015. Am J Ophthalmol. 2007. PMID: 17893018 No abstract available.
Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study.
Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell P. Wong TY, et al. Among authors: mitchell p. Ophthalmology. 2008 Nov;115(11):1869-75. doi: 10.1016/j.ophtha.2008.05.014. Epub 2008 Jun 26. Ophthalmology. 2008. PMID: 18584872
Systemic management of diabetic retinopathy.
Liew G, Mitchell P, Wong TY. Liew G, et al. Among authors: mitchell p. BMJ. 2009 Feb 12;338:b441. doi: 10.1136/bmj.b441. BMJ. 2009. PMID: 19213762 No abstract available.
C-reactive protein, body mass index, and diabetic retinopathy.
Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, Wong TY. Lim LS, et al. Among authors: mitchell p. Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4458-63. doi: 10.1167/iovs.09-4939. Invest Ophthalmol Vis Sci. 2010. PMID: 20805569
Mixed messages on systemic therapies for diabetic retinopathy.
Lim LS, Liew G, Cheung N, Mitchell P, Wong TY. Lim LS, et al. Among authors: mitchell p. Lancet. 2010 Oct 30;376(9751):1461; author reply 1462. doi: 10.1016/S0140-6736(10)61984-8. Lancet. 2010. PMID: 21036265 No abstract available.
Diabetic retinopathy screening and monitoring of early stage disease in general practice: design and methods.
Askew DA, Crossland L, Ware RS, Begg S, Cranstoun P, Mitchell P, Jackson CL. Askew DA, et al. Among authors: mitchell p. Contemp Clin Trials. 2012 Sep;33(5):969-75. doi: 10.1016/j.cct.2012.04.011. Epub 2012 May 1. Contemp Clin Trials. 2012. PMID: 22575797 Clinical Trial.
Fenofibrate - a potential systemic treatment for diabetic retinopathy?
Wong TY, Simó R, Mitchell P. Wong TY, et al. Among authors: mitchell p. Am J Ophthalmol. 2012 Jul;154(1):6-12. doi: 10.1016/j.ajo.2012.03.013. Am J Ophthalmol. 2012. PMID: 22709833 Review.
Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives.
Simó R, Roy S, Behar-Cohen F, Keech A, Mitchell P, Wong TY. Simó R, et al. Among authors: mitchell p. Curr Med Chem. 2013;20(26):3258-66. doi: 10.2174/0929867311320260009. Curr Med Chem. 2013. PMID: 23745548 Review.
Diabetic Retinopathy Screening and Monitoring of Early Stage Disease in Australian General Practice: Tackling Preventable Blindness within a Chronic Care Model.
Crossland L, Askew D, Ware R, Cranstoun P, Mitchell P, Bryett A, Jackson C. Crossland L, et al. Among authors: mitchell p. J Diabetes Res. 2016;2016:8405395. doi: 10.1155/2016/8405395. Epub 2015 Dec 20. J Diabetes Res. 2016. PMID: 26798655 Free PMC article. Clinical Trial.
3,831 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page